X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs NATCO PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA NATCO PHARMA ABBOTT INDIA/
NATCO PHARMA
 
P/E (TTM) x 33.1 34.7 95.3% View Chart
P/BV x 8.3 17.7 46.8% View Chart
Dividend Yield % 0.8 0.6 125.5%  

Financials

 ABBOTT INDIA   NATCO PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
NATCO PHARMA
Mar-14
ABBOTT INDIA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs6,015877 685.9%   
Low Rs3,707424 875.3%   
Sales per share (Unadj.) Rs1,236.9223.4 553.6%  
Earnings per share (Unadj.) Rs122.231.1 393.3%  
Cash flow per share (Unadj.) Rs129.040.3 320.3%  
Dividends per share (Unadj.) Rs35.005.00 700.0%  
Dividend yield (eoy) %0.70.8 93.6%  
Book value per share (Unadj.) Rs521.2219.5 237.5%  
Shares outstanding (eoy) m21.2533.07 64.3%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x3.92.9 135.0%   
Avg P/E ratio x39.820.9 190.1%  
P/CF ratio (eoy) x37.716.1 233.4%  
Price / Book Value ratio x9.33.0 314.8%  
Dividend payout %28.616.1 178.0%   
Avg Mkt Cap Rs m103,29621,504 480.4%   
No. of employees `0003.0NA-   
Total wages/salary Rs m3,3701,128 298.8%   
Avg. sales/employee Rs Th8,891.8NM-  
Avg. wages/employee Rs Th1,140.0NM-  
Avg. net profit/employee Rs Th878.3NM-  
INCOME DATA
Net Sales Rs m26,2847,389 355.7%  
Other income Rs m504167 301.9%   
Total revenues Rs m26,7897,556 354.5%   
Gross profit Rs m3,6651,793 204.4%  
Depreciation Rs m144304 47.4%   
Interest Rs m8366 2.2%   
Profit before tax Rs m4,0171,290 311.5%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,421309 460.3%   
Profit after tax Rs m2,5961,027 252.7%  
Gross profit margin %13.924.3 57.5%  
Effective tax rate %35.423.9 147.8%   
Net profit margin %9.913.9 71.0%  
BALANCE SHEET DATA
Current assets Rs m14,4463,681 392.4%   
Current liabilities Rs m4,7253,123 151.3%   
Net working cap to sales %37.07.6 489.3%  
Current ratio x3.11.2 259.4%  
Inventory Days Days5189 57.4%  
Debtors Days Days2059 33.3%  
Net fixed assets Rs m1,1137,685 14.5%   
Share capital Rs m213331 64.3%   
"Free" reserves Rs m10,8086,670 162.0%   
Net worth Rs m11,0767,259 152.6%   
Long term debt Rs m0955 0.0%   
Total assets Rs m16,24111,957 135.8%  
Interest coverage x497.04.5 10,989.6%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.60.6 261.9%   
Return on assets %16.011.7 137.6%  
Return on equity %23.414.2 165.6%  
Return on capital %36.320.7 175.4%  
Exports to sales %0.639.4 1.6%   
Imports to sales %12.65.7 221.7%   
Exports (fob) Rs m1622,908 5.6%   
Imports (cif) Rs m3,322421 788.8%   
Fx inflow Rs m2683,445 7.8%   
Fx outflow Rs m3,927703 558.8%   
Net fx Rs m-3,6592,743 -133.4%   
CASH FLOW
From Operations Rs m2,5141,440 174.6%  
From Investments Rs m-800-1,089 73.4%  
From Financial Activity Rs m-803-353 227.6%  
Net Cashflow Rs m912-1 -61,201.3%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 1.5 5,102.0%  
Indian inst/Mut Fund % 7.9 7.8 100.8%  
FIIs % 0.1 16.6 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 26.0 65.8%  
Shareholders   18,270 25,395 71.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 17, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ASTRAZENECA PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS